EPIC Test Compendium Alpha
Welcome to the new Northwell Health Labs Test Directory, please call our Client Services Department at 1-800-472-5757 with any typos, corrections or issues.

OnkoSight Myeloid Seq

Test Catalog Information

Test Catalog Synonyms

EPIC Synonyms OnkoMyelo
Cerner Primary MnemonicOnkoSight Myeloid Seq
EPIC Display NameOnkoSight Myeloid Seq
Allscripts (AEHR) Order Name

OnkoSight Myeloid Seq.

Sunrise Clinical Manager (SCM) Order Name

OnkoSight Myeloid Disorder Panel

EPIC Inpatient Orderable Yes
EPIC Outpatient Orderable Yes
Cerner Results MYE Gen 1
MYE Interp
MYE REF 2
MYE Allele Frequencies
MYE Prog
MYE Gen 2
MYE REF 1
MYE Addendum
Onko Myelo Seq
MYE CT 1
MYE TECH
MYE Report1
MYE Meth
MYE CT 2
Clinical Info

Tumor sequencing by NGS detecting mutations in 50 genes associated with myeloid malignancies. Mutations often have prognostic significance, may confer resistance to FDA approved therapies, or may qualify patients for late-stage clinical trials.

Specimen Type

Blood, Bone Marrow

Container

Sterile

Collection Instructions

Peripheral Blood - Lavender Top or  Green Top Tube Bone Marrow - Green Top Eppendorf tube, Unstained Slide, Formalin-fixed, Paraffin-embedded Tissue Decalcified specimens are not recommended for NGS testing  **  Note: Please indicate specimen type on tube **                  Test Code TL95

Transport Instructions

Room Temperature

Specimen Stability

7 Days Refrigerated Blood samples older than 7 days can still be shipped, they will be tested if the yield and quality of DNA permit.

Methodology

Genotyping by Next Generation Sequencing Includes: Genes ABL1; ANKRD26; ASXL1; ATRX; BCOR; BCORL1; BRAF CALR; CBL; CCND2; CDKN2; CEBPA: CSF3R; CUX1 DDX41: DNMT3A: ETNK1: ETV6: EZH2: FBXW7; FLT3 GATA2; HRAS; IDH1; JAK2; KDM6A; KIT; KMT2A; KRAS MAP2K1; MPL; MYD88; NF1; NPM1; NRAS; PDGFRA PHF6; PTEN; PTPN11; RUNX1; SETBP1; SF3B1; SRSF2 STAG2; TET2; TP53; U2AF1; WT1; ZRSR2

Days Performed

TAT: 10 - 12 Days

Performing Laboratory

Genpath BioReference

CPT

81450 81451

PDM

1659893

Desired Epic Build OnkoSight Myeloid Seq

Cerner Primary Mnemonic: OnkoSight Myeloid Seq
PDM 1659893
Informatics - WorkgroupMolecular-send outs
Synonyms *OnkoMyelo
Display Name *OnkoSight Myeloid Seq
Order Entry Specimen Sources *
Order Entry Specimen Types
Blood
Bone Marrow
Tissue
Specimen Navigator Specimen Types
Specimen Navigator Specimen Sources
Specimen Navigator Short Name
Ordering info (EPIC SmartText)Tumor sequencing by NGS detecting mutations in 50 genes associated with myeloid malignancies. Mutations often have prognostic significance, may confer resistance to FDA approved therapies, or may qualify patients for late-stage clinical trials.
IP Orderable Yes
OP Orderable Yes
AOEs *

AOE PDMAOE DisplayAOE DescriptionPrompt
AOE00021 Diagnosis Under Consideration: Diagnosis Under Consideration: X
AOE00022 Anatomic Location of Primary Lesion : Anatomic Location of Primary Lesion : X
AOE00023 HemPath Source HemPath Source X
AOE00024 Initial Diagnosis or Relapse Initial Diagnosis or Relapse X
AOE00025 Number of Prior Treatment Number of Prior Treatment X
AOE00026 Prior Treatment Prior Treatment X
AOE00027 TNM Staging Clinical TNM Staging Clinical X
AP AOEs
Special History No
Build Comments
Filter *genetics
Procedure Category Change
Cerner Results

Result DescResult displayResult PDM
MYE Gen 1 MYE Gen 1 1659893D
MYE Interp MYE Interp 1659893C
MYE REF 2 MYE REF 2 1659893K
MYE FREQ MYE Allele Frequencies 1659893N
MYE Prog MYE Prog 1659893B
MYE Gen 2 MYE Gen 2 1659893E
MYE REF 1 MYE REF 1 1659893J
MYE ADD MYE Addendum 1659893M
OnkoSight Myeloid Onko Myelo Seq 1659893A
MYE CT 1 MYE CT 1 1659893F
MYE TECH MYE TECH 1659893H
MYE Report1 MYE Report1 1659893L
MYE Meth MYE Meth 1659893I
MYE CT 2 MYE CT 2 1659893G

Actual Epic build

Procedure Id 111548
Pdm 1659893
Order Display Name OnkoSight Myeloid Seq
Procedure Name ONKOSIGHT NGS MYELOID MALIGNANCIES PANEL
Procedure Master Number LAB10522
Short Procedure Name ONKOSIGHT NGS MYELOID MALIGNANCIES PANEL
Category Code 1.0
Category Code Record Name LAB BLOOD ORDERABLES
Synonyms ONKOMYELO
Clinically Active Yes
Orderable Yes
Performable Yes
Filter Genomics Generic Genomics Procedure
Reference Link Url https://labs.northwell.edu/epic/test/111548
Ordering Instructions
Default Specimen Type Blood
Specimen Type Pick List Bone Marrow Blood
Specimen Type List
Op Specimen Type List
Specimen Source Pick List Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous Bone Marrow Aspirate
Specimen Source Default - Male
Specimen Source Default - Female
Specimen Source List
Op Specimen Source List
Ip Lab Test Components For Report
Op Lab Test Components For Report
Order Questions ["3046000078", "3046000079", "3046000080", "3046000081", "3046000082", "3046000083", "3046000084", "3045300170", "3045300171", "3045300173"]
Order Questions Record Name NH IP DX UNDER CONS NH IP ANATOMIC LOCATION OF PRIMARY LESION NH IP HEMPATH SOURCE NH IP INITIAL DX OR RELAPSE NH IP NUMBER OF PRIOR TREATMENT NH IP PRIOR TREATMENT NH IP TNM STAGING CLINICAL NH IP HOME COLLECT DATE NH IP HOME COLLECT DAYS NH IP HOME COLLECT MEDICALLY NECESSARY
Inpatient Order Questions ["3046000078", "3046000079", "3046000080", "3046000081", "3046000082", "3046000083", "3046000084"]
Inpatient Order Questions Record Name NH IP DX UNDER CONS NH IP ANATOMIC LOCATION OF PRIMARY LESION NH IP HEMPATH SOURCE NH IP INITIAL DX OR RELAPSE NH IP NUMBER OF PRIOR TREATMENT NH IP PRIOR TREATMENT NH IP TNM STAGING CLINICAL
Order Specific Question Override Yes
Inpatient Question Override
Location Restrict List Ip
Location Restrict List Ip Record Name
Location Restrict List Include Ip
Location Restrict List Op
Location Restrict List Op Record Name
Location Restrict List Includes Op
Edp Amb Order Specific Questions Record Name
Edp Ip Order Specific Questions Record Name
Edp Ip Specimen Source Blood, Venous Blood, Central Line Blood, Arterial Blood, Capillary
Edp Op Specimen Source
Edp Ip Specimen Type Blood
Edp Op Specimen Type
Derived Edp Ip Buttons S Blood, Capillary Blood, Venous Blood, Central Line Blood, Arterial
Derived Edp Ip Buttons T Blood
Derived Edp Op Buttons S
Derived Edp Op Buttons T
Ip Orderable 1
Op Orderable 1
EPIC OP AOEs

Question IDQuestion NameQuestionResponse TypeResponse ListRequire Response
3045300170 NH IP HOME COLLECT DATE Start Date Date Yes
3045300171 NH IP HOME COLLECT DAYS Days Custom List Monday
Tuesday
Wednesday
Thursday
Friday
Saturday
Sunday
Yes
3045300173 NH IP HOME COLLECT MEDICALLY NECESSARY Medically Necessary? Yes/No Yes
3046000078 NH IP DX UNDER CONS Diagnosis Under Consideration: Free Text No
3046000079 NH IP ANATOMIC LOCATION OF PRIMARY LESION Anatomic Location of Primary Lesion: Free Text No
3046000080 NH IP HEMPATH SOURCE HemPath Source Free Text No
3046000081 NH IP INITIAL DX OR RELAPSE Initial Diagnosis or Relapse Free Text No
3046000082 NH IP NUMBER OF PRIOR TREATMENT Number of Prior Treatment Free Text No
3046000083 NH IP PRIOR TREATMENT Prior Treatment Free Text No
3046000084 NH IP TNM STAGING CLINICAL TNM Staging Clinical: Free Text No
EPIC IP AOEs

Question IDQuestion NameQuestionResponse TypeResponse ListRequire Response
3046000078 NH IP DX UNDER CONS Diagnosis Under Consideration: Free Text No
3046000079 NH IP ANATOMIC LOCATION OF PRIMARY LESION Anatomic Location of Primary Lesion: Free Text No
3046000080 NH IP HEMPATH SOURCE HemPath Source Free Text No
3046000081 NH IP INITIAL DX OR RELAPSE Initial Diagnosis or Relapse Free Text No
3046000082 NH IP NUMBER OF PRIOR TREATMENT Number of Prior Treatment Free Text No
3046000083 NH IP PRIOR TREATMENT Prior Treatment Free Text No
3046000084 NH IP TNM STAGING CLINICAL TNM Staging Clinical: Free Text No
EPIC Components (results)

Component IDComponent NameBase NameCommon NameExternal NameCerner Result PDM
3047803677.0 MYE DETAILED GENETIC INTERPRETATION 1 MYEGENINT1 MYE DETAILED GENETIC INTERPRETATION 1 1659893D
3047803679.0 MYE INTERPRETATION SUMMARY MYEINTERP MYE INTERPRETATION SUMMARY 1659893C
3047803683.0 MYE REFERENCES 2 MYEREF2 MYE REFERENCES 2 1659893K
3047803674.0 MYE ALLELE FREQUENCIES MYE MYE ALLELE FREQUENCIES 1659893N
3047803681.0 MYE THERAPEUTIC AND PROGNOSTIC ASSOCIATIONS MYEPROG MYE THERAPEUTIC AND PROGNOSTIC ASSOCIATIONS 1659893B
3047803678.0 MYE DETAILED GENETIC INTERPRETATION 2 MYEGENINT2 MYE DETAILED GENETIC INTERPRETATION 2 1659893E
3047803682.0 MYE REFERENCES 1 MYEREF1 MYE REFERENCES 1 1659893J
3047803673.0 MYE ADDENDUM MYE MYE ADDENDUM 1659893M
3046000187.0 ONKOSIGHT MYELOID SEQUENCE ONKOMYSEQ ONKO MYELO SEQ 1659893A
3047803675.0 MYE CLINICAL TRIALS 1 MYECT1 MYE CLINICAL TRIALS 1 1659893F
3047803685.0 MYE TECHNICAL SUMMARY MYETECH MYE TECHNICAL SUMMARY 1659893H
3047803684.0 MYE REPORT FOOTER MYEREPORT MYE REPORT FOOTER 1659893L
3047803680.0 MYE METHODS MYEMETHOD MYE METHODS 1659893I
3047803676.0 MYE CLINICAL TRIALS 2 MYECT2 MYE CLINICAL TRIALS 2 1659893G